Resultados de la búsqueda 21-30 of 9630 for monoclonal antibody

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

2. Cirugía - Ensayos clínicos - Mayo Clinic

   Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as daratumumab, may ... monoclonal antibody, and compare them with clinical outcomes. Registry for ...

4. Cirugía - Ensayos clínicos - Mayo Clinic

   Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...

5. Hematología - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such ... Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin.

6. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. ... * Whether the body makes antibodies ...

7. Hematología - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work ...

8. Hematología - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. ... * Whether the body makes antibodies ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer ...

10. Cirugía - Ensayos clínicos - Mayo Clinic

    Cetuximab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as ...